Are anlotinib and cabozantinib essentially the same?

Cabozantinib (Cabozantinib) and Anlotinib are two targeted drugs used to treat tumors. They have similar mechanisms of action and indications to a certain extent. Both drugs have shown certain efficacy in clinical applications. Cabozantinib is mainly used to treat advanced renal cell carcinoma, advanced hepatocellular carcinoma and medullary thyroid cancer. It is an oral drug that inhibits multiple signaling pathways required for tumor growth and metastasis, and has the ability to inhibit tumor cell invasion and migration. Anlotinib is a targeted therapy drug for non-small cell lung cancer, mainly for patients with positive ALK or ROS1 gene rearrangements. Anlotinib can inhibit the expression of these genes, thereby inhibiting the growth and spread of tumor cells.